ChemoMetec A/S reported earnings results for the half year ended December 31, 2022. For the half year, the company reported sales was DKK 240.6 million compared to DKK 209.81 million a year ago. Net income was DKK 105.42 million compared to DKK 85.19 million a year ago.

Basic earnings per share from continuing operations was DKK 6.06 compared to DKK 4.9 a year ago. Diluted earnings per share from continuing operations was DKK 6.06 compared to DKK 4.9 a year ago.